LOS ANGELES, March 29, 2017 -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against AmTrust Financial Services, Inc. (“AmTrust” or the “Company”) (Nasdaq:AFSI) concerning possible violations of federal securities laws between March 2, 2015 and March 16, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired AmTrust shares during the Class Period should contact the firm prior to the May 1, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
The complaint alleges that during the Class Period, AmTrust and certain of its executives violated federal securities laws. On February 27, 2017 the Company revealed that it “identified material weaknesses in its internal control over financial reporting that existed as of December 31, 2016, specifically related to ineffective assessment of the risks associated with the financial reporting, and an insufficient complement of corporate accounting and corporate financial reporting resources within the organization.” When this news was revealed to the public, the value of AmTrust shares dropped, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 



